Search research articles
Contact Us
Filters
Showing results (1-10 of 53) with videos related to
Page
of 6
Sort By:
Current Hypertension Reports
|
May 26, 2005
Alcohol consumption and hypertension
Michael Huntgeburth, Henrik Ten Freyhaus, Stephan Rosenkranz
Cardiology in the Young
|
August 12, 2020
Interventional recanalisation of long segment aortic atresia
Michael Huntgeburth, Wael Ahmad, Jan Brunkwall, et al.
Pharmacogenetics
|
November 27, 2004
The Arg389Gly beta1-adrenoceptor gene polymorphism determines contractile response to catecholamines
Karl La Rosée, Michael Huntgeburth, Stephan Rosenkranz, et al.
Pulmonary Circulation
|
February 16, 2019
High-risk pregnancy in a patient with pulmonary arterial hypertension due to congenital heart disease (PAH-CHD) with temporary shunt inversion and deoxygenation
Christopher Hohmann, Daniel Dumitrescu, Felix Gerhardt, et al.
FEBS Letters
|
December 5, 2006
PI3-kinase/Akt-dependent antiapoptotic signaling by the PDGF alpha receptor is negatively regulated by Src family kinases
Marius Vantler, Michael Huntgeburth, Evren Caglayan, et al.
Clinical Drug Investigation
|
September 22, 2018
Riociguat for the Treatment of Raynaud's Phenomenon: A Single-Dose, Double-Blind, Randomized, Placebo-Controlled Cross-Over Pilot Study (DIGIT)
Michael Huntgeburth, Johannes Kießling, Gerrit Weimann, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
October 18, 2005
17Beta-estradiol attenuates PDGF signaling in vascular smooth muscle cells at the postreceptor level
Kai Kappert, Evren Caglayan, Michael Huntgeburth, et al.
Cardiovascular Diagnosis and Therapy
|
November 19, 2019
Emerging clinical applications of strain imaging and three-dimensional echocardiography for the assessment of ventricular function in adult congenital heart disease
Michael Huntgeburth, Ingo Germund, Lianne M Geerdink, et al.
Neurocritical Care
|
July 10, 2013
Changes in neuron-specific enolase are more suitable than its absolute serum levels for the prediction of neurologic outcome in hypothermia-treated patients with out-of-hospital cardiac arrest
Michael Huntgeburth, Christoph Adler, Stephan Rosenkranz, et al.
Archives of Internal Medicine
|
January 25, 2006
Phosphodiesterase type 5 inhibition is a novel therapeutic option in Raynaud disease
Evren Caglayan, Michael Huntgeburth, Thomas Karasch, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 53) with videos related to
Sort By:
Page
of 6
Current Hypertension Reports
|
May 26, 2005
Alcohol consumption and hypertension
Michael Huntgeburth, Henrik Ten Freyhaus, Stephan Rosenkranz
Cardiology in the Young
|
August 12, 2020
Interventional recanalisation of long segment aortic atresia
Michael Huntgeburth, Wael Ahmad, Jan Brunkwall, et al.
Pharmacogenetics
|
November 27, 2004
The Arg389Gly beta1-adrenoceptor gene polymorphism determines contractile response to catecholamines
Karl La Rosée, Michael Huntgeburth, Stephan Rosenkranz, et al.
Pulmonary Circulation
|
February 16, 2019
High-risk pregnancy in a patient with pulmonary arterial hypertension due to congenital heart disease (PAH-CHD) with temporary shunt inversion and deoxygenation
Christopher Hohmann, Daniel Dumitrescu, Felix Gerhardt, et al.
FEBS Letters
|
December 5, 2006
PI3-kinase/Akt-dependent antiapoptotic signaling by the PDGF alpha receptor is negatively regulated by Src family kinases
Marius Vantler, Michael Huntgeburth, Evren Caglayan, et al.
Clinical Drug Investigation
|
September 22, 2018
Riociguat for the Treatment of Raynaud's Phenomenon: A Single-Dose, Double-Blind, Randomized, Placebo-Controlled Cross-Over Pilot Study (DIGIT)
Michael Huntgeburth, Johannes Kießling, Gerrit Weimann, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
October 18, 2005
17Beta-estradiol attenuates PDGF signaling in vascular smooth muscle cells at the postreceptor level
Kai Kappert, Evren Caglayan, Michael Huntgeburth, et al.
Cardiovascular Diagnosis and Therapy
|
November 19, 2019
Emerging clinical applications of strain imaging and three-dimensional echocardiography for the assessment of ventricular function in adult congenital heart disease
Michael Huntgeburth, Ingo Germund, Lianne M Geerdink, et al.
Neurocritical Care
|
July 10, 2013
Changes in neuron-specific enolase are more suitable than its absolute serum levels for the prediction of neurologic outcome in hypothermia-treated patients with out-of-hospital cardiac arrest
Michael Huntgeburth, Christoph Adler, Stephan Rosenkranz, et al.
Archives of Internal Medicine
|
January 25, 2006
Phosphodiesterase type 5 inhibition is a novel therapeutic option in Raynaud disease
Evren Caglayan, Michael Huntgeburth, Thomas Karasch, et al.
Page
of 6